| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/21/2005 | EP1061805B1 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/21/2005 | EP0994710B2 Pharmaceutical compositions for oral administration, comprising a benzhydrylpiperazine and a cyclodextrin |
| 09/21/2005 | EP0776337B1 Growth differentiation factor-11 |
| 09/21/2005 | CN1671745A Polysaccharide of echinacea angustifolia |
| 09/21/2005 | CN1671741A Buffered formulations for concentrating antibodies and methods of use thereof |
| 09/21/2005 | CN1671715A Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 09/21/2005 | CN1671713A Novel derivative of flavone c-glycoside and composition containing the same |
| 09/21/2005 | CN1671701A Novel aryllimidazole derivatives, preparation and therapeutic used thereof |
| 09/21/2005 | CN1671696A 激酶抑制剂 Kinase inhibitors |
| 09/21/2005 | CN1671694A Bisindolyl-maleimid derivatives as kinase inhibitors |
| 09/21/2005 | CN1671671A 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im |
| 09/21/2005 | CN1671668A 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 09/21/2005 | CN1671666A Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines |
| 09/21/2005 | CN1671662A Piperidine derivative, process for producing the same, and use |
| 09/21/2005 | CN1671639A Novel biphenyl and biphenyl-like cannabinoids |
| 09/21/2005 | CN1671413A Vaccine composition comprising transferrin bindin derived from gram-negative bacteria and HSF |
| 09/21/2005 | CN1671407A Compositions and methods for treating diabetes |
| 09/21/2005 | CN1671404A Compositions for preventing or treating pollenosis, allergic nephritis, atopic dermatitits, asthma or urticaria |
| 09/21/2005 | CN1671398A Compositions and methods for treating epithelia and retinal tissue diseases |
| 09/21/2005 | CN1671395A Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 09/21/2005 | CN1671379A Hydrazonopyrazole derivatives and their use as therapeutics |
| 09/21/2005 | CN1669566A Preparation method of Astragaloside material medicine, the material medicine and preparation |
| 09/21/2005 | CN1669558A Medicinal composition containing panax ginseng polysaccharide |
| 09/21/2005 | CN1669557A Bacill calmette-guerin polysaccharide nucleic acid spraying agent and preparation method thereof |
| 09/21/2005 | CN1669476A Novel health food and drink containing marine algae |
| 09/21/2005 | CN1219796C Application of N-end amino acid of interferon-tau polypeptide |
| 09/21/2005 | CN1219780C Heterocyclic compounds binding chemotactic factor receptor |
| 09/21/2005 | CN1219763C Substituted indole mannich bases |
| 09/21/2005 | CN1219539C Immune regulatorand its use in producing medicine |
| 09/21/2005 | CN1219520C External preparations for treating dermatitis |
| 09/21/2005 | CN1219510C Benzimidazole derivatives as modulators of IgE |
| 09/21/2005 | CN1219509C Use of rosmarinic acid and derivatives thereof as immunosuppressant or inhibitor of SHz-mediated process |
| 09/20/2005 | US6946548 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs. |
| 09/20/2005 | US6946486 Quaternary ammonium compounds |
| 09/20/2005 | US6946478 Compounds |
| 09/20/2005 | US6946459 Crystalline forms of 1s-[1alpha(2s*,3r*), 9alpha]6, 10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9[[(1-isoquinolyl) carbonyl]amino]octahydro-6h-piridazino[1,2-a][1,2]diazepin-1-carboxamide |
| 09/20/2005 | US6946445 peptide antagonists of CXC chemokine receptor 4, CXCR4; cancer and autoimmune diseases; protein that comprises an N-terminal sequence of KGVSLSYR (SEQ ID NO: 3); stromal cell derived factor one (SDF-1 ligand |
| 09/20/2005 | US6946244 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 09/20/2005 | US6946131 Comprises heparan sulfate proteoglyeans; antiproliferative agents |
| 09/20/2005 | US6946129 Recombinant anti-CD40 antibody and uses thereof |
| 09/20/2005 | US6946121 Composition in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method |
| 09/20/2005 | CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same |
| 09/15/2005 | WO2005085291A1 A kind of fusion protein, gene encoding it, expression method and use thereof |
| 09/15/2005 | WO2005085212A1 Substituted pyrimidine derivative |
| 09/15/2005 | WO2005085210A1 Nitriles and medicinal compositions containing the same as the active ingredient |
| 09/15/2005 | WO2005084704A1 Digestive bypass composition for arthropod and uses thereof |
| 09/15/2005 | WO2005084689A1 Radix astragli extract and production method and use thereof |
| 09/15/2005 | WO2005084662A1 The euphorbia lunulate bge extractant and production method and use thereof |
| 09/15/2005 | WO2005027966A3 Antibodies with altered effector functions |
| 09/15/2005 | WO2004111086A3 Peptide analogues comprising at least one type of aminoacyl aza-$g(b)3 and the use thereof, in particular for therapy |
| 09/15/2005 | WO2003000844A3 Protein modification and maintenance molecules |
| 09/15/2005 | US20050203282 For screening of agonists and antagonists of receptor which may have advantageous pharmaceutical or diagnostical properties; for identification of patients who may present genetic disorders induced by inactive receptor |
| 09/15/2005 | US20050203158 Substituted benzimidazole compounds |
| 09/15/2005 | US20050203153 Drugs with carriers as prodrugs for anticancer agents |
| 09/15/2005 | US20050203141 Polymorphic forms 2 and 3 of bilastin is transformed into polymorph 1, which is very stable and is not transformed into any of the other polymorphs 2 and 3; allergic reactions, pathological processes mediated by histamine |
| 09/15/2005 | US20050203135 Modulating adhesion between intracellular adhesion molecules (e.g. ICAM-1, -2 and -3) and the leukocyte integrin family of receptors; inflammatory disorders, allergies, and autoimmune diseases such as psoriasis, rheumatoid arthritis, asthma, multiple sclerosis, transplant rejection |
| 09/15/2005 | US20050203118 Rheumatic diseases; antiarthritic agents; multiple sclerosis; antidiabetic agents; asthma therapy; skin disorders |
| 09/15/2005 | US20050203116 Desloratadine salts,process for their synthesis and pharmaceutical compositions thereof |
| 09/15/2005 | US20050203114 Pyrimidine-indole derivatives; cancer, autoimmunological, metabolic, inflammatory, infection (bacterial, viral, yeast, fungal, etc.), diseases of the central nervous system, degenerative neural disease, allergy/asthma, dermatology, angiogenesis, neovascularization, vasculogenesis, and cardiovascular |
| 09/15/2005 | US20050203109 Novel Compounds |
| 09/15/2005 | US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/15/2005 | US20050203073 Method of treating inflammatory conditions with progesterone or progesterone analogs |
| 09/15/2005 | US20050202553 Animal cells and processes for the replication of influenza viruses |
| 09/15/2005 | US20050202529 Humanised antibodies |
| 09/15/2005 | US20050202474 Phosphodiesterases |
| 09/15/2005 | US20050202411 Preparing biopsy of tumorous tissue and monitoring chemosensitivity to anticarcinogenic agents; antitumor agents |
| 09/15/2005 | US20050202410 Precise efficacy assay methods for active agents inlcluding chemotherapeutic agents |
| 09/15/2005 | US20050202032 Use of neglected target tissue antigens in modulation of immune responses |
| 09/15/2005 | US20050202027 Multivalent compounds for crosslinking receptors and uses thereof |
| 09/15/2005 | US20050202013 Novel Th2-specific molecules and uses thereof |
| 09/15/2005 | US20050202011 Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith |
| 09/15/2005 | US20050201996 Administering a probiotic to a household pet; contact dermatitis, actinic dermatitis, dermatitis caused by microbial infection, eczema and rosacea |
| 09/15/2005 | US20050201984 An adenoviral genome replaced with a therapeutic gene or DNA sequence regulated by a ubiquitous promoter either a Cytomegalo virus promotor or a tissue-specific phosphoenolpyruvate carboxykinase promoter, where gene or sequence encodes for a latent human metalloprotease gene MMP-8 (collengenases) |
| 09/15/2005 | US20050201979 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders |
| 09/15/2005 | US20050201977 Amino-terminally truncated MCP-2 as chemokine antagonists |
| 09/15/2005 | US20050201962 Modified Porphyran |
| 09/15/2005 | CA2558399A1 Partially loaded antibodies and methods of their conjugation |
| 09/15/2005 | CA2558167A1 Amino acid derivatives |
| 09/15/2005 | CA2557645A1 Caspase inhibitors and uses thereof |
| 09/15/2005 | CA2556386A1 Isothiourea derivatives |
| 09/14/2005 | EP1574577A2 Growth differentiation factor-11 |
| 09/14/2005 | EP1574219A2 Method of inhibiting fibrosis with a somatostatin agonist |
| 09/14/2005 | EP1573025A2 Crystallized structure of type iv collagen nc1 domain hexamer |
| 09/14/2005 | EP1572995A2 Novel proteins and nucleic acids encoding same |
| 09/14/2005 | EP1572989A1 Gen 2.2 dendritic cell line |
| 09/14/2005 | EP1572976A2 Modulating immune responses |
| 09/14/2005 | EP1572933A2 Modulation of immune response by non-peptide binding stress response polypeptides |
| 09/14/2005 | EP1572930A2 Albumin-fused kunitz domain peptides |
| 09/14/2005 | EP1572898A2 Novel proteins and nucleic acids encoding same |
| 09/14/2005 | EP1572881A2 Tacis and br3 polypeptides and uses thereof |
| 09/14/2005 | EP1572877A2 Drug metabolizing enzymes |
| 09/14/2005 | EP1572876A2 Transcriptional regulation of target genes |
| 09/14/2005 | EP1572875A2 Receptors and membrane-associated proteins |
| 09/14/2005 | EP1572874A2 Antibodies that immunospecifically bind to trail receptors |
| 09/14/2005 | EP1572868A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 09/14/2005 | EP1572864A2 Human serpin polypeptides |
| 09/14/2005 | EP1572863A2 Method for identifying inhibitors of g protein coupled receptor signaling |
| 09/14/2005 | EP1572689A1 Tetracyclic immunomodulatory compounds |
| 09/14/2005 | EP1572241A1 Oral pharmaceutical compositions comprising cyclosporin |
| 09/14/2005 | EP1572183A1 Alpha-2-delta ligand for the treatment of sexual dysfunction |